Logo
Nazad
William Migo, M. Bošković, R. Likić
4 1. 10. 2021.

The development of biologics to target SARS-CoV2: Treatment potential of antibodies in patient groups with poor immune response


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više